Trial · NCT03409744
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Treatment-Emergent Adverse Events (TEAEs) Up to Week 216 | Up to 216 weeks | Number of participants | NUMBER | |
| SECONDARY | Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | Percentage of change | MEAN |
| SECONDARY | Absolute Change in LDL-C Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | mg/dL | MEAN |
| SECONDARY | Percent Change in Apolipoprotein B (Apo B) Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | Percentage of change | MEAN |
| SECONDARY | Absolute Change in Apo B Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | mg/dL | MEAN |
| SECONDARY | Percent Change in Non-High-Density Lipoprotein Cholesterol (HDL-C) Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | Percentage of change | MEAN |
| SECONDARY | Absolute Change in Non-HDL-C Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | mg/dL | MEAN |
| SECONDARY | Percent Change in Total Cholesterol (TC) Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | Percentage of change | MEAN |
| SECONDARY | Absolute Change in TC Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | mg/dL | MEAN |
| SECONDARY | Percent Change in Triglycerides (TGs) Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | Percentage of change | MEAN |
| SECONDARY | Absolute Change in TGs Over Time | Up to 120 weeks | Here 'n' = number of evaluable participants at the specified timepoint | mg/dL | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03409744/outcomes